Growth Metrics

Myr (MYRG) EBITDA (2016 - 2025)

Historic EBITDA for Myr (MYRG) over the last 16 years, with Q3 2025 value amounting to $30.3 million.

  • Myr's EBITDA rose 15342.87% to $30.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.6 million, marking a year-over-year increase of 14396.47%. This contributed to the annual value of $21.5 million for FY2024, which is 7699.18% down from last year.
  • Per Myr's latest filing, its EBITDA stood at $30.3 million for Q3 2025, which was up 15342.87% from $31.3 million recorded in Q2 2025.
  • Myr's 5-year EBITDA high stood at $31.3 million for Q2 2025, and its period low was -$16.4 million during Q2 2024.
  • For the 5-year period, Myr's EBITDA averaged around $19.1 million, with its median value being $21.6 million (2021).
  • In the last 5 years, Myr's EBITDA tumbled by 16738.21% in 2024 and then skyrocketed by 29050.46% in 2025.
  • Myr's EBITDA (Quarter) stood at $20.8 million in 2021, then rose by 24.59% to $25.9 million in 2022, then grew by 3.58% to $26.8 million in 2023, then plummeted by 64.48% to $9.5 million in 2024, then soared by 218.43% to $30.3 million in 2025.
  • Its EBITDA was $30.3 million in Q3 2025, compared to $31.3 million in Q2 2025 and $23.4 million in Q1 2025.